Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
VRTX compared with QNT: revenue, margins and what each company keeps, and the suppliers and customers both name
VRTX
Vertex Pharmaceuticals Inc
Change
Mkt cap
Revenue
Revenue
QNT
Quantinuum Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
VRTX
Vertex Pharmaceuticals Inc
vs
QNT
Quantinuum Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
VRTX
0 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±4.9%
▼
−4.05%
×0.82
Q2 FY26
±5.2%
▲
+1.70%
×0.33
Q1 FY26
±5.4%
▼
−1.28%
×0.24
Feb 13 '26
±6.0%
▲
+5.69%
×0.95
QNT
2 of 4 reports
2 of 2
at or beyond implied
Report
implied
realized
× implied
Nov 6 '26
±15.7%
▲
+25.99%
×1.66
Q2 FY26
±13.0%
▲
+27.97%
×2.15
= implied
VRTX realized, solid
QNT realized, hatched
One scale, both sides: full bar = 28%
× = |realized| ÷ implied
span: VRTX 263d · QNT 86d
Source: market data
VRTX
Vertex Pharmaceuticals Inc
Change
547.31
▲
+0.89%
· post 547.09
Mkt cap
$138.7B
Revenue
$3.4B
Q3 FY26
Revenue
$12.0B
FY25
QNT
Quantinuum Inc.
Change
37.57
▲
+25.97%
· post 37.20
Closed
Nov 6 '26
Mkt cap
$1.3B
Revenue
$8M
Q2 FY26
Revenue
—
vs
Compare
Closed
Nov 6 '26
VRTX
Vertex Pharmaceuticals Inc
vs
QNT
Quantinuum Inc.
547.31
▲
+0.89%
post 547.09
Price
37.57
▲
+25.97%
post 37.20
$138.7B
Mkt cap
$1.3B
Q3 FY26
$3.4B
Revenue
$8M
Q2 FY26
FY25
$12.0B
Revenue
—
Change
Change
VRTX
547.31
▲
+0.89%
vs
QNT
37.57
▲
+25.97%
Closed
Nov 6 '26